The knockdown of CUGBP1 in HSCs by VA-Lip-siRNA-CUGBP1 improved the liver fibrosis in mice and fraxinellone was not able to promote the improvement (Fig. 8d–f). The gene discussed is CELF1; the disease is Hepatic fibrosis.